Research Project
Grant-in-Aid for Young Scientists (B)
Assessment of therapeutic efficiency for malignant glioma patient is traditionally accomplished by measuring changes in tumor size in gadolinium-enhanced T1-weighted MRI at 10 weeks after treatment has been administered. In this study, we evaluated glioblastoma (GB) patients treated by boron neutron capture therapy (BNCT) by using this fDM analysis. The maximum volume of tumor with decrease diffusion by fDM within 7 days was the strongest predictor of patients' survival time since BNCT. The fDM could provide an earlier imaging assessment of the prognosis of GB patients treated by BNCT.
All 2009
All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (17 results)
CI研究 31巻
Pages: 145-151
10026325247
CI研究 31